Skip to main content
. 2022 Nov 24;11(4):74. doi: 10.3390/antib11040074

Figure 3.

Figure 3

ADCC reporter assay by EpMab-37-mG2a-f and 281-mG2a-f in the presence of BT-474 and Capan-2 cells. (A,B) Target cells (BT-474 (A) and Capan-2 (B)) were treated with serially diluted EpMab-37-mG2a-f and 281-mG2a-f (mouse IgG2a control). Then, Jurkat cells stably expressing the human FcγRIIIa receptor and an NFAT response element driving firefly luciferase were added and co-cultured. Luminescence was measured using the Bio-Glo Luciferase Assay System. ADCC, antibody-dependent cellular cytotoxicity.